Simcere Pharmaceutical schließt eine Forschungskooperationsvereinbarung mit Stanford Medicine zur Entwicklung innovativer Therapien für Patienten mit idiopathischer Lungenfibrose

SHANGHAI, 13. Juni 2026 /PRNewswire/ — Am 29. Mai 2026 (Pacific Time) schloss die Simcere Pharmaceutical Group Limited (2096.HK) eine Forschungskooperationsvereinbarung mit Stanford Medicine ab, um gemeinsam eine explorative Studie im Bereich der Atemwegserkrankungen voranzutreiben, mit…

Healthcare Insights Desk

Welcome to the Healthcare Insights Desk at TheUnplanned.in, where we delve deep into the world of health and wellness. Our dedicated team of writers brings you authoritative articles, expert opinions, and insightful analyses on all facets of healthcare.


Discover more from The Unplanned

Subscribe to get the latest posts sent to your email.

Scroll to Top

Discover more from The Unplanned

Subscribe now to keep reading and get access to the full archive.

Continue reading

Verified by MonsterInsights